Dyne Therapeutics Inc (DYN)
29.73
-0.26
(-0.87%)
USD |
NASDAQ |
Nov 21, 16:00
29.36
-0.37
(-1.24%)
Pre-Market: 08:07
Dyne Therapeutics Total Assets (Quarterly): 768.84M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 768.84M |
| June 30, 2024 | 825.88M |
| March 31, 2024 | 522.28M |
| December 31, 2023 | 165.08M |
| September 30, 2023 | 205.24M |
| June 30, 2023 | 251.42M |
| March 31, 2023 | 288.64M |
| December 31, 2022 | 306.32M |
| September 30, 2022 | 299.68M |
| June 30, 2022 | 340.03M |
| Date | Value |
|---|---|
| March 31, 2022 | 387.76M |
| December 31, 2021 | 425.66M |
| September 30, 2021 | 466.88M |
| June 30, 2021 | 467.15M |
| March 31, 2021 | 491.71M |
| December 31, 2020 | 353.33M |
| September 30, 2020 | 381.47M |
| June 30, 2020 | 146.77M |
| December 31, 2019 | 16.44M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
16.44M
Minimum
Dec 2019
825.88M
Maximum
Jun 2024
374.24M
Average
353.33M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 3.600B |
| Capricor Therapeutics Inc | 92.95M |
| Regenxbio Inc | 519.11M |
| Catalyst Pharmaceuticals Inc | 772.01M |
| Novavax Inc | 1.712B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 63.30M |
| Shareholders Equity (Quarterly) | 705.54M |